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Introduction: Primary malignant melanoma of the urethra is an extremely rare disease
associated with a poor prognosis due to early metastasis and often delayed diagnosis. There
is limited literature on this entity, especially with regard to radiologic imaging.
Presentation of case: The case presented is a 67-year-old African American woman with
primary urethral melanoma who underwent bladder-sparing surgery based upon pelvic
magnetic resonance imaging (MRI) ﬁndings.
Discussion: MRI can be used for diagnosis of primary urethral melanoma and evaluation of
tumor extent for surgical planning purposes.
Conclusion: Pelvic exenteration is often required for primary urethral melanoma treatment,
though bladder conservation surgery may be a viable option in patients without evidence of
bladder invasion on MRI.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary malignant melanoma of the urethra is an extremely
rare entity with a poor prognosis due to its early metastasis
and often delayed diagnosis. There is limited literature
regarding primary urethral melanoma, particularly involving
the utility of magnetic resonance imaging (MRI) for diagnosis
and surgical planning purposes. A case of primary malignant.01.003
hed by Elsevier Ltd. This is an op
/by-nc-nd/4.0/).
953 7930.
yo.edu (D. Amiraian).melanoma of the urethra is presented. The patient is a 67-year-
old African American woman with pathology proven primary
urethral melanoma without evidence of metastatic disease,
who underwent bladder-sparing surgery based upon pelvic MRI
ﬁndings. MRI can be integral for both diagnosis and surgical
planning in patients with primary urethral melanoma.2. Case
An otherwise healthy 67-year-old African American woman
presented to an outside facility with obstructive voidingen access article under the CC BY-NC-ND license
Figure 3 Urethral mass without hyperintensity on coronal
T1 MRI.
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during which friable tissue in the posterior urethra was
identiﬁed and biopsied. Pathologic results were consistent
with the diagnosis of urethral melanoma. An outside PET
scan was reportedly negative for metastatic disease, and
the patient was referred to our institution for further care.
Upon transfer, the physical examination was remarkable
for a palpable and partially mobile urethral mass without
suprapubic tenderness or lymphadenopathy. Pelvic MRI was
performed with and without gadolinium. The MRI demon-
strated an extremely well-circumscribed, avidly enhancing
tumor centered in the posterior mid-urethral wall measur-
ing 2.3 (right–left) 2.0 (anterior–posterior) 2.4 (cranial–
caudal) cm. The lesion was uniformly isointense on T2,
without T1 hyperintensity. There was mass effect poster-
iorly upon the anterior vaginal wall. No lymphadenopathy or
metastasis was identiﬁed (Figures 1–4).
Based upon the pelvic MRI ﬁndings, the patient under-
went a total urethrectomy, bladder augmentation using the
right colon, and formation of a continent catheterizable
stoma using the terminal ileum. A bilateral pelvic lymphFigure 1 Round, circumscribed, isointense urethral mass on
coronal T2 MRI.
Figure 2 Round, circumscribed, isointense posterior urethral
mass with mass effect on the vagina on sagittal T2 MRI.
Figure 4 Round, circumscribed, enhancing posterior urethral
mass with mass effect on the vagina on sagittal post-contrast
fat-saturated MRI.node dissection was also performed. Surgical pathology
revealed both invasive and in situ malignant melanoma of
the urethra, with negative resection margins. Frozen sec-
tions of the adjacent vaginal mucosa and proximal urethral
margin were negative for malignancy. All 20 dissected pelvic
lymph nodes were benign. A diagnosis of primary urethral
malignant melanoma was made based upon the presence of
in situ tumor cells containing melanin pigment. Also, the
outside biopsy was positive for S-100, melan-A, and vimen-
tin. BRAF V600 mutation testing was performed and was
negative for mutation (Figure 5).3. Discussion
Primary malignant melanoma of the urethra is an extremely
rare entity, comprising less than 1% of all melanomas [1] and
15Primary malignant melanoma of the urethra4% of urethral malignancies [2,3]. Melanocytes arise from
neuroectodermal tissue and are found within all cutaneous
and many mucosal sites [4]. The urethra is of endodermal
origin, which helps explain the low incidence of urethral
melanoma [1]. Some postulate that abnormal developmen-
tal migration of melanocytes can result in embryonic rests
in atypical anatomic locations, leading to unusual sites of
melanoma. Another hypothesis is that varying melanocyte
density contributes to melanoma incidence at speciﬁc
anatomic sites [4]. Interestingly, the mucocutaneous vulva
contains a relatively high concentration of melanocytes,
likely rendering females more susceptible to urethral mel-
anoma [1]. Accordingly, urethral melanoma has a 3:1 female
predominance [1,3] and occurs most often in the distal
urethra and meatus [1–4].
Average age at diagnosis of urethral melanoma is 65 years
[1]. Common presenting symptoms include a palpable
urethral mass and obstructive voiding symptoms [1,2,4].
Microscopically, urethral melanoma has a variable appear-
ance. Between 1.8% and 8.1% of all melanomas are amela-
notic, requiring speciﬁc immunohistochemical stains such as
S-100 and melan-A for diagnosis [2].
Compared to primary cutaneous malignant melanomas,
urethral melanoma has a worse prognosis due to delayed
diagnosis and early metastasis [5,6]. Metastatic spread is
often via superﬁcial and deep lymphatic drainage to local
sites such as the vulva, vagina, and inguinal lymph nodes.
Distant metastases are typically via hematogenous spread
[1]. Approximately half of patients with urethral melanomaFigure 5 (A) Urothelial epithelium underwent squamous meta
spreading pattern, occasionally spreading into top of epithelium. No
underwent squamous metaplasia. Brown melanin pigment within t
arise from basal epithelium and invade downward beyond epitheliu
within invasive tumor cell cytoplasm. Basal in situ component is pres
brown melanin-containing tumor cells.have metastatic disease at the time of their diagnosis [1].
Timely diagnosis and subsequent appropriate intervention
are beneﬁcial.
MRI has become a pivotal diagnostic and surgical planning
tool for urethral pathology, including malignant melanoma.
MRI allows for multiplanar imaging, as well as superior
pelvic tissue differentiation and contrast resolution over
other radiologic modalities [3]. MRI helps determine the size
and location of urethral lesions, with 90% accuracy in
determining local tumor extension [7,8]. Tumor extension
is best visualized on sagittal T2 imaging [7,8]. Urethral
tumors, such as carcinomas and leiomyomas, have classi-
cally been described as T1 hypointense and relatively T2
hyperintense [7,8]. Urethral diverticula are the most com-
mon cystic urethral lesions. When urethral diverticula are
uncomplicated, they are T1 hypointense and T2 hyperin-
tense. Their ﬂuid intensity and diverticular ostium can
distinguish diverticula from solid urethral tumors.
Melanoma may not follow the same MRI intensity pattern
as other urethral tumors since its appearance may depend
on intralesional melanin content. Melanin is a paramagnetic
substance within melanocytes, with a short T1 relaxation
time that creates high T1 signal intensity. Thus, melanotic
melanoma is bright on T1 images, while amelanotic mela-
noma will lack this feature. Intralesional hemorrhage can
also result in T1 hyperintensity. There is relatively recent
debate regarding whether melanin versus intralesional
hemorrhage causes the T1 hyperintensity in melanoma. A
2012 study concluded that melanin content alone does notplasia. Brown melanin-containing tumor cells with pagetoid
invasive component within this focus. (B) Urothelial epithelium
umor cytoplasm is identiﬁed. Melanoma tumor cells appear to
m. (C) Higher power of ﬁgure B shows brown melanin pigment
ent on left of image. (D) Numerous mitoses along with scattered
D. Amiraian et al.16signiﬁcantly affect T1 or T2 relaxation time on MRI [9];
however, this matter continues to be debated. Homoge-
neous contrast enhancement is typically seen with mela-
noma [3]. Once a diagnosis of urethral melanoma is
conﬁrmed, MRI can help guide appropriate surgical inter-
vention based upon determination of tumor extension and/
or metastatic spread.
First line treatment of urethral melanoma is typically
surgical, usually with urethrectomy and bilateral inguinal
lymph node dissection or pelvic exenteration. Adjuvant
chemotherapy, radiotherapy, and immunotherapy are also
often needed for effective treatment [1]. Surgical resection
of the tumor is necessary for local management and to try
to prevent local recurrence or more distant metastatic
disease. The current literature suggests that partial distal
urethrectomy may not provide sufﬁcient surgical margins to
control the disease and that pelvic exenteration is more
effective. However, for certain patients without bladder
invasion, radical urethrectomy and bladder conservation
with catheterizable stoma formation may be a viable option
[6]. MRI therefore serves as an essential tool for evaluating
tumor extent for surgical planning purposes.4. Conclusion
Primary malignant melanoma of the urethra is an extremely
rare disease with a poor prognosis due to early metastatic
spread and often delayed diagnosis. There is limited litera-
ture to date on the role of radiologic imaging in the
diagnosis and treatment of primary urethral melanoma.
This pathology proven case report highlights the utility of
MRI as an integral radiologic tool for the diagnosis and
ultimate surgical treatment of primary urethral melanoma.Consent
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